Search Results for "Drug Interactions"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Drug Interactions. Results 451 to 460 of 1090 total matches.
In Brief: A New Indication for Pemigatinib (Pemazyre) (online only)
The Medical Letter on Drugs and Therapeutics • Apr 17, 2023 (Issue 1674)
, every
2 months for the first 6 months, and every 3 months
thereafter.
DRUG INTERACTIONS — Pemigatinib ...
The oral kinase inhibitor pemigatinib (Pemazyre –
Incyte) has been approved by the FDA for treatment
of adults with relapsed or refractory myeloid/lymphoid neoplasms (MLNs) with fibroblast growth
factor receptor 1 (FGFR1) rearrangements. It is the
first targeted therapy to be approved in the US for this
indication. The drug received accelerated approval
from the FDA in 2020 for treatment of adults with
previously treated, unresectable, locally advanced or
metastatic cholangiocarcinoma with FGFR2 fusions
or other rearrangements.
Med Lett Drugs Ther. 2023 Apr 17;65(1674):e71-2 doi:10.58347/tml.2023.1674g | Show Introduction Hide Introduction
Maribavir (Livtencity) for Cytomegalovirus Infection (online only)
The Medical Letter on Drugs and Therapeutics • Nov 28, 2022 (Issue 1664)
ganciclovir/valganciclovir
(9.4% vs 33.9%).
DRUG INTERACTIONS — Maribavir is metabolized
primarily by CY3A4 ...
Maribavir (Livtencity – Takeda), an oral cytomegalovirus
(CMV) pUL97 kinase inhibitor, has been
approved by the FDA for treatment of post-transplant
CMV infection refractory to standard antiviral therapy
in patients ≥12 years old who weigh at least 35 kg.
Rimantadine for Prevention and Treatment of Influenza
The Medical Letter on Drugs and Therapeutics • Nov 26, 1993 (Issue 910)
.
DRUG INTERACTIONS — Concurrent use of cimetidine (Tagamet) can increase and aspirin or
acetaminophen ...
Rimantadine hydrochloride (Flumadine - Forest), the alpha-methyl derivative of amantadine (Symmetrel, and others), was recently approved by the US Food and Drug Administration for prevention and treatment of influenza A virus infections in adults and for prevention of influenza in children.
Naltrexone For Alcohol Dependence
The Medical Letter on Drugs and Therapeutics • Jul 21, 1995 (Issue 953)
for as long as 36 months (D Sax et al,
J Clin Pharmacol, 34:898, 1994).
DRUG INTERACTIONS — Lethargy ...
Naltrexone (ReVia -DuPont Pharma), a long-acting oral opioid antagonist previously marketed for treatment of opioid dependence under the trade name Trexan, was recently approved by the US Food and Drug Administration (FDA) for treatment of alcohol dependence. The new trade name will now also be used for the old indication.
Brexanolone (Zulresso) for Postpartum Depression
The Medical Letter on Drugs and Therapeutics • May 06, 2019 (Issue 1571)
the drug.
DRUG INTERACTIONS — Administration of
brexanolone with other CNS depressants could result ...
The FDA has approved the GABAA receptor modulator
brexanolone (Zulresso – Sage Therapeutics) for
IV treatment of postpartum depression (PPD).
Brexanolone is the first drug to be approved by the FDA
for this indication.
Colesevelam (Welchol) For Hypercholesterolemia
The Medical Letter on Drugs and Therapeutics • Oct 30, 2000 (Issue 1091)
interacts with thyroid hormones, thiazide and furosemide diuretics and other drugs that bind ...
Colesevelam hydrochloride (Welchol - Sankyo Pharma), a nonabsorbed hydrophilic polymer that binds bile acids, has been approved by the FDA for reduction of plasma LDL cholesterol in patients with primary hypercholesterolemia.
Caplacizumab (Cablivi) for iTTP
The Medical Letter on Drugs and Therapeutics • Oct 19, 2020 (Issue 1609)
, and urticaria were also reported with
use of the drug.
DRUG INTERACTIONS — Concomitant use of
caplacizumab ...
Caplacizumab-yhdp (Cablivi – Sanofi /Genzyme), a
von Willebrand factor-directed antibody fragment, has
been approved by the FDA for use in combination with
plasma exchange and immunosuppressive therapy
for treatment of immune-mediated thrombotic
thrombocytopenic purpura (iTTP; formerly called
acquired thrombotic thrombocytopenic purpura
[aTTP]) in adults. It is the first drug to be approved in
the US for this indication.
Oral Balsalazide (Colazal) For Ulcerative Colitis
The Medical Letter on Drugs and Therapeutics • Jul 23, 2001 (Issue 1109)
occurred with mesalamine.
DRUG INTERACTIONS — In vitro, mesalamine from balsalazide or any ...
Balsalazide disodium (Colazal), a prodrug of mesalamine, was marketed in the US this year for oral treatment of mildly to moderately active ulcerative colitis. Oral formulations of mesalamine have been available in the US for nine years for treatment and maintenance of remissions and olsalazine, which is a dimer of mesalamine, is marketed for maintenance of remissions but not for treatment. Balsalazide has been available in Europe for four years.
Fluvoxamine for COVID-19?
The Medical Letter on Drugs and Therapeutics • May 03, 2021 (Issue 1623)
; 11:eaau5266.
5. Drug interactions from The Medical Letter. Available at:
www.medicalletter.org ...
A recent article in JAMA and an interview of its senior
author on 60 Minutes have heightened interest in
off-label use of the oral selective serotonin reuptake
inhibitor (SSRI) fluvoxamine (Luvox, and generics) to
treat COVID-19.
Mifepristone (Korlym) for Cushing's Syndrome
The Medical Letter on Drugs and Therapeutics • Jun 11, 2012 (Issue 1392)
and for 1 month after the last dose.
DRUG INTERACTIONS — Strong inhibitors of
CYP3A4, such as ketoconazole ...
The FDA has approved the antiprogestin mifepristone
(Korlym – Corcept Therapeutics) for control of hyperglycemia
secondary to hypercortisolism in adults with
endogenous Cushing’s syndrome who have type 2 diabetes/
glucose intolerance and have not responded to,
or are not candidates for, surgery. Formerly known as
RU 486, mifepristone is also available in a lower
strength as Mifeprex for use in terminating an early
intrauterine pregnancy.